These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 24880100)

  • 21. The Ubiquitous Pharmacogenomics consortium: making effective treatment optimization accessible to every European citizen.
    Manson LE; van der Wouden CH; Swen JJ; Guchelaar HJ
    Pharmacogenomics; 2017 Jul; 18(11):1041-1045. PubMed ID: 28685652
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical Applications of Personalized Medicine: A New Paradigm and Challenge.
    Di Sanzo M; Cipolloni L; Borro M; La Russa R; Santurro A; Scopetti M; Simmaco M; Frati P
    Curr Pharm Biotechnol; 2017; 18(3):194-203. PubMed ID: 28240172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The challenges of delivering pharmacogenomics into clinical pediatrics.
    Leeder JS; Kearns GL
    Pharmacogenomics J; 2002; 2(3):141-3. PubMed ID: 12082583
    [No Abstract]   [Full Text] [Related]  

  • 24. PACE Forward-Making Pharmacogenomics Testing Available for Real-Life Clinical Utility.
    Lazaridis KN
    Clin Pharmacol Ther; 2019 Jan; 105(1):42-44. PubMed ID: 30520030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacogenomic phase transition from personalized medicine to patient-centric customized delivery.
    Radhakrishnan A; Kuppusamy G; Ponnusankar S; Shanmukhan NK
    Pharmacogenomics J; 2020 Feb; 20(1):1-18. PubMed ID: 31819163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacogenetics: The right drug for you.
    Drew L
    Nature; 2016 Sep; 537(7619):S60-2. PubMed ID: 27602742
    [No Abstract]   [Full Text] [Related]  

  • 27. Implementation of Pharmacogenetics at Cincinnati Children's Hospital Medical Center: Lessons Learned Over 14 Years of Personalizing Medicine.
    Ramsey LB; Prows CA; Zhang K; Saldaña SN; Sorter MT; Pestian JP; Wenstrup RJ; Vinks AA; Glauser TA
    Clin Pharmacol Ther; 2019 Jan; 105(1):49-52. PubMed ID: 30058217
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacogenomics: paving the path to personalized medicine.
    Patrinos GP; Innocenti F
    Pharmacogenomics; 2010 Feb; 11(2):141-6. PubMed ID: 20136354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Precision Medicine and the Changing Landscape of Research Ethics.
    Hammer MJ
    Oncol Nurs Forum; 2016 Mar; 43(2):149-50. PubMed ID: 26906126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetics and genomics: the scientific drivers of personalized medicine.
    Kurnat-Thoma EL
    Annu Rev Nurs Res; 2011; 29():27-54. PubMed ID: 22891497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacogenomics in the clinic.
    Relling MV; Evans WE
    Nature; 2015 Oct; 526(7573):343-50. PubMed ID: 26469045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pediatric pharmacogenetic and pharmacogenomic studies: the current state and future perspectives.
    Russo R; Capasso M; Paolucci P; Iolascon A;
    Eur J Clin Pharmacol; 2011 May; 67 Suppl 1():17-27. PubMed ID: 21069522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid point of care testing: the next frontier in pharmacogenomics.
    Leach M; Newman WG; McDermott JH
    Pharmacogenomics; 2024; 25(7):289-291. PubMed ID: 39041736
    [No Abstract]   [Full Text] [Related]  

  • 34. Pediatric pharmacogenomics: challenges and opportunities: on behalf of the Sanford Children's Genomic Medicine Consortium.
    Gregornik D; Salyakina D; Brown M; Roiko S; Ramos K
    Pharmacogenomics J; 2021 Feb; 21(1):8-19. PubMed ID: 32843689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What do we need to transfer pharmacogenetics findings into the clinic?
    Slob EMA; Vijverberg SJH; Pijnenburg MW; Koppelman GH; Maitland-van der Zee AH
    Pharmacogenomics; 2018 May; 19(7):589-592. PubMed ID: 29701121
    [No Abstract]   [Full Text] [Related]  

  • 36. Advancing Pharmacogenomics as a Component of Precision Medicine: How, Where, and Who?
    Johnson JA; Weitzel KW
    Clin Pharmacol Ther; 2016 Feb; 99(2):154-6. PubMed ID: 26440500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Personalised medicine. Aims and challenges].
    Bieber T; Broich K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1468-72. PubMed ID: 24170075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Personalized medicine, pharmacogenomic and companion biomarker.
    Manceau H; Amrani K; Peoc'h K
    Ann Biol Clin (Paris); 2017 Dec; 75(6):631-636. PubMed ID: 29192598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Editorial: SNPs of drug metabolic enzymes and personalized medicine Part II.
    Wei DQ; Chen Q
    Curr Drug Metab; 2012 Sep; 13(7):951. PubMed ID: 22475268
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of pharmacogenetics and pharmacogenomics in 21st-century medicine: state of the art and new challenges discussed in the VII Conference of the Spanish Pharmacogenetics and Pharmacogenomics Society (SEFF).
    Rodriguez-Antona C
    Drug Metab Pers Ther; 2016 Mar; 31(1):1-2. PubMed ID: 26641977
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.